NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Magnet Biomedicine

Magnet Biomedicine

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://magnetbio.com/

Last Round

Strategic

Feb 28, 2025

Total Funding Raised

$70M

Company Overview

Magnet Biomedicine is a biotechnology company that operates a research platform focused on advanced molecular glue discovery to enhance therapeutic impact through innovative applications of human biology and proteomics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

molecular gluedrug discoveryprotein degradationtargeted protein degradationTPDrational drug designbiotech platformproteomicsundruggable targetsproximity-inducing drugsdrug discovery platformbiopharma partnershipprotein interactionsmall molecule therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Magnet Biomedicine Comparables

Compare Magnet Biomedicine with similar companies based on industry and business-model similarity.

Magnet Biomedicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neomorph
91%
Ambagon Therapeutics
88%
Rapafusyn Pharmaceuticals
88%

Magnet Biomedicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicFeb 28, 2025
Series A ExtensionNov 1, 2023
Series ASep 19, 2023

Key People

Founding team and executive leadership

Brian Safina

President CEO

Executive Team

Magnet Biomedicine Investors

Notable investors and investment history

Magnet Biomedicine investors
InvestorRounds
Newpath PartnersSeries A Extension, Series A
ARCH Venture PartnersSeries A Extension, Series A
Taiho VenturesSeries A Extension
ARCH Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 4, 2025

    Bharat Reddy appointed as new Chief Business Officer.

  • Nov 1, 2023

    $20M round with Taiho Ventures, ARCH Venture Partners, and Newpath Partners.

Magnet Biomedicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Magnet Biomedicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Magnet Biomedicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range41
Year Founded2019
Last FundingFeb 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.